SP Epstein, EJ Bottone, PA Asbell - Eye & Contact Lens, 2006 - journals.lww.com
Purpose. Pseudomonas aeruginosa ocular infections most frequently originate from an environmental source; successful treatment with various ocular antibiotics is well …
NA Chaudhry, HW Flynn Jr, TG Murray… - American journal of …, 1999 - Elsevier
PURPOSE: To report a clinical series of ciprofloxacin-resistant ocular isolates of Pseudomonas aeruginosa from a tertiary care ophthalmic center. METHODS: Review of in …
MK Rhee, RP Kowalski, EG Romanowski… - American journal of …, 2004 - Elsevier
PURPOSE: The emergence of ciprofloxacin-resistant Pseudomonas aeruginosa (CRPA) has created a new therapeutic challenge in ophthalmology. We evaluated ophthalmic …
JA Lomholt, M Kilian - British journal of ophthalmology, 2003 - bjo.bmj.com
Aim: To examine the ciprofloxacin susceptibility of 106 Pseudomonas aeruginosa eye isolates from the United Kingdom, Denmark, India, the United States, and Australia, and to …
OBJECTIVE: To determine ciprofloxacin resistance of corneal isolates of Pseudomonas and to review the clinical response to topical therapy in cases of ciprofloxacin-resistant …
MDP Willcox - Clinical and Experimental Optometry, 2011 - Taylor & Francis
Background: Microbial keratitis is a rare disease but most commonly caused by bacterial infection. Two of the most common bacteria to cause microbial keratitis are Pseudomonas …
Purpose.: To determine the association of type III secretion system (T3SS) genotype with antibiotic susceptibility, serotypes, and clinical manifestation of centrally located …
Treatment of Pseudomonas aeruginosa eye infections often becomes a challenge due to the ability of this bacterium to be resistant to antibiotics via intrinsic and acquired mechanisms …
istered to the eye separately, at least 5 min apart. 10 Although dual therapy provides the broad spectrum antimicrobial activity necessary for initial empirical therapy in bacterial …